Illinois General Assembly - Bill Status for SB2265
Illinois General Assembly

Previous General Assemblies

 Bill Status of SB2265  98th General Assembly


Short Description:  NURSING HOMES-DRUG TREATMENT

Senate Sponsors
Sen. Dave Syverson, Patrick J. Joyce, David Koehler and Laura M. Murphy

House Sponsors
(Rep. Norine K. Hammond - Frances Ann Hurley, Tony McCombie, Amy Grant, C.D. Davidsmeyer, Jackie Haas, Bradley Stephens, Thomas M. Bennett, Patrick Windhorst, Jaime M. Andrade, Jr. and Robyn Gabel)

Last Action
DateChamber Action
  5/12/2021HousePlaced on Calendar 2nd Reading - Short Debate

Statutes Amended In Order of Appearance
210 ILCS 45/2-106.1


Synopsis As Introduced
Amends the Nursing Home Care Act. In provisions requiring the Department of Public Health to adopt a protocol specifying how informed consent for psychotropic medication may be obtained or refused that requires a discussion between the resident or the resident's surrogate decision maker and the resident's physician, a registered pharmacist, or a licensed nurse about the possible risks and benefits of a recommended medication and the use of standardized consent forms designated by the Department, (i) removes language prohibiting the registered pharmacist from being a dispensing pharmacist for the facility where the resident lives and (ii) specifies that a licensed nurse includes a licensed practical nurse. Provides that specified forms shall be designated (rather than developed) by the Department and may be able to be downloaded from a website designated by the Department (other than the Department's official website). Provides that the maximum possible period for informed consent shall be until a change in the prescription occurs as to the change in the type of psychotropic medication or an increase in dosage (rather than a change in dosage), unless the physician's order for which informed consent was given provides for an increase in dosage. Effective immediately.

Senate Floor Amendment No. 1
Replaces everything after the enacting clause with the provisions of the introduced bill with the following changes. Provides that each form designated or developed (rather than designated) by the Department of Public Health shall conform with specified requirements. Provides that the maximum possible period for informed consent shall be until a change in the prescription occurs as to the change in the type of psychotropic medication or an increase or decrease in dosage, dosage range, or titration schedule of the prescribed medication that was not included in the original informed consent (rather than the change in the type of psychotropic medication or an increase in dosage, unless the physician's order for which informed consent was given provides for an increase in dosage). Provides that when informed consent is not required for a change in dosage, the facility shall note in the resident's file that the resident was informed of the dosage change prior to the administration of the medication or that verbal, written, or electronic notice has been communicated to the resident's surrogate decision maker that a change in dosage has occurred. Effective immediately.

Actions 
DateChamber Action
  2/26/2021SenateFiled with Secretary by Sen. Dave Syverson
  2/26/2021SenateFirst Reading
  2/26/2021SenateReferred to Assignments
  3/23/2021SenateAssigned to Health
  3/31/2021SenateTo Subcommittee on Long-Term Care & Aging
  4/6/2021SenateReported Back To Health; 005-000-000
  4/12/2021SenateAdded as Co-Sponsor Sen. Patrick J. Joyce
  4/13/2021SenateAdded as Co-Sponsor Sen. David Koehler
  4/14/2021SenateDo Pass Health; 013-000-000
  4/14/2021SenatePlaced on Calendar Order of 2nd Reading April 15, 2021
  4/15/2021SenateSenate Floor Amendment No. 1 Filed with Secretary by Sen. Dave Syverson
  4/15/2021SenateSenate Floor Amendment No. 1 Referred to Assignments
  4/16/2021SenateAdded as Co-Sponsor Sen. Laura M. Murphy
  4/20/2021SenateSenate Floor Amendment No. 1 Assignments Refers to Health
  4/20/2021SenateSenate Floor Amendment No. 1 Recommend Do Adopt Health; 011-000-000
  4/20/2021SenateSenate Floor Amendment No. 1 Adopted; Syverson
  4/20/2021SenateSecond Reading
  4/20/2021SenatePlaced on Calendar Order of 3rd Reading April 21, 2021
  4/21/2021SenateThird Reading - Passed; 054-000-000
  4/22/2021HouseArrived in House
  4/22/2021HouseChief House Sponsor Rep. Norine K. Hammond
  4/23/2021HouseFirst Reading
  4/23/2021HouseReferred to Rules Committee
  4/28/2021HouseAssigned to Human Services Committee
  5/6/2021HouseAdded Alternate Co-Sponsor Rep. Tony McCombie
  5/6/2021HouseAdded Alternate Co-Sponsor Rep. Amy Grant
  5/6/2021HouseAdded Alternate Co-Sponsor Rep. C.D. Davidsmeyer
  5/6/2021HouseAdded Alternate Co-Sponsor Rep. Jackie Haas
  5/6/2021HouseAdded Alternate Co-Sponsor Rep. Bradley Stephens
  5/6/2021HouseAdded Alternate Co-Sponsor Rep. Thomas M. Bennett
  5/6/2021HouseAdded Alternate Co-Sponsor Rep. Patrick Windhorst
  5/10/2021HouseAdded Alternate Co-Sponsor Rep. Jaime M. Andrade, Jr.
  5/10/2021HouseAdded Alternate Chief Co-Sponsor Rep. Frances Ann Hurley
  5/12/2021HouseAdded Alternate Co-Sponsor Rep. Robyn Gabel
  5/12/2021HouseDo Pass / Short Debate Human Services Committee; 015-000-000
  5/12/2021HousePlaced on Calendar 2nd Reading - Short Debate

Back To Top